A study by DZNE and the University Hospital Bonn suggests that assessments of the eye’s retina could help to detect a loss of brain substance, i. e. “brain atrophy”.
DZNE scientist Markus Zweckstetter has been awarded 150,000 euros by the European Research Council to test potential drugs against Alzheimer’s disease in laboratory studies.
Findings by DZNE researchers and partners support the view that hyperactive immune cells in the brain can have a protective effect in the course of neurodegenerative diseases.
A consortium led by DZNE has been tasked with investigating whether patients with “dementia of unclear etiology” benefit from examination of the brain using amyloid PET.
Long before the onset of dementia, there is evidence for increased activity of the brain’s immune system. Researchers from DZNE and the University Hospital Bonn come to this conclusion based on a study of more than 1,000 older adults.
Ahmad Aziz, scientist at DZNE’s Bonn site, has been awarded a “Starting Grant” from the European Research Council (ERC) worth around 1.5 million euros. With this funding, he aims to investigate the extent to which certain patterns in the genetic code contribute to the…
Some viral diseases could possibly contribute to neurodegeneration. DZNE researchers report this in the scientific journal “Nature Communications” on the basis of laboratory experiments.
Welcome to our website, here you can inform yourself basically cookie-free.
We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.
